CREB3L2
Cyclic AMP-responsive element-binding protein 3-like protein 2
Also known as: BBF2H7, CR3L2_HUMAN, TCAG_1951439
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q70SY1
- Gene
- CREB3L2
- Ensembl
- ENSG00000182158
- Chromosome
- 7
- Canonical length
- 520 aa
- Protein class
- Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Endoplasmic reticulum
OverviewNCBI Gene
This gene encodes a member of the oasis bZIP transcription factor family. Members of this family can dimerize but form homodimers only. The encoded protein is a transcriptional activator. Translocations between this gene on chromosome 7 and the gene fused in sarcoma on chromosome 16 can be found in some tumors. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
Canonical amino-acid sequenceUniProt
520 residues, UniProt reviewed canonical sequence.
>Q70SY1|CREB3L2
1 MEVLESGEQG VLQWDRKLSE LSEPGDGEAL MYHTHFSELL DEFSQNVLGQ LLNDPFLSEK
61 SVSMEVEPSP TSPAPLIQAE HSYSLCEEPR AQSPFTHITT SDSFNDDEVE SEKWYLSTDF
121 PSTSIKTEPV TDEPPPGLVP SVTLTITAIS TPLEKEEPPL EMNTGVDSSC QTIIPKIKLE
181 PHEVDQFLNF SPKEAPVDHL HLPPTPPSSH GSDSEGSLSP NPRLHPFSLP QTHSPSRAAP
241 RAPSALSSSP LLTAPHKLQG SGPLVLTEEE KRTLIAEGYP IPTKLPLSKS EEKALKKIRR
301 KIKNKISAQE SRRKKKEYMD SLEKKVESCS TENLELRKKV EVLENTNRTL LQQLQKLQTL
361 VMGKVSRTCK LAGTQTGTCL MVVVLCFAVA FGSFFQGYGP YPSATKMALP SQHSLQEPYT
421 ASVVRSRNLL IYEEHSPPEE SSSPGSAGEL GGWDRGSSLL RVSGLESRPD VDLPHFIISN
481 ETSLEKSVLL ELQQHLVSAK LEGNETLKVV ELDRRVNTTFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CREB3L2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 61 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 61 nTPM
- parathyroid gland: 56 nTPM
- blood vessel: 46 nTPM
- placenta: 37 nTPM
- choroid plexus: 32 nTPM
- endometrium: 31 nTPM
Single-cell type
- plasma cells: 698 nCPM
- choroid plexus epithelial cells: 342 nCPM
- syncytiotrophoblasts: 325 nCPM
- corticotrophs: 309 nCPM
- salivary acinar cells: 304 nCPM
- extravillous trophoblasts: 243 nCPM
Immune cell
- T-reg: 13 nTPM
- plasmacytoid DC: 12 nTPM
- basophil: 9.9 nTPM
- MAIT T-cell: 9.8 nTPM
- memory CD8 T-cell: 8.2 nTPM
- gdT-cell: 7.3 nTPM
Brain region
- choroid plexus: 102 nTPM
- white matter: 40 nTPM
- thalamus: 38 nTPM
- cerebral cortex: 34 nTPM
- basal ganglia: 33 nTPM
- medulla oblongata: 32 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.66
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.03
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cartilage development
- chondrocyte differentiation
- endoplasmic reticulum to Golgi vesicle-mediated transport
- positive regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- response to endoplasmic reticulum stress
- response to unfolded protein
Molecular functions
- cAMP response element binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- transcription cis-regulatory region binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CREB3L2 as an antibody target. Whether an autoantibody or antibody against CREB3L2 could matter depends on whether native CREB3L2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CREB3L2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CREB3L2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...